Evidence map›Paper›PMID 28201653›Full record

ArticleNucleic acids research2017

TIEG1 modulates β-catenin sub-cellular localization and enhances Wnt signaling in bone.

Malayannan Subramaniam, Muzaffer Cicek, Kevin S Pitel, Elizabeth S Bruinsma, Molly H Nelson Holte, Sarah G Withers, Nalini M Rajamannan, Frank J Secreto, K Venuprasad, John R Hawse

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. KLF transcription factors in bone diseases.Journal of cellular and molecular medicine · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Connexin43 enhances Wnt and PGE2-dependent activation of β-catenin in osteoblasts.Pflugers Archiv : European journal of physiology · 2019
    Article
  12. TIEG1 is upregulated in Lrp5/6-mediated valve osteogenesis.Journal of cellular biochemistry · 2019
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Malayannan SubramaniamDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Muzaffer CicekDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Kevin S PitelDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Elizabeth S BruinsmaDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Molly H Nelson HolteDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Sarah G WithersDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Nalini M RajamannanDivision of Cardiology, Most Sacred Heart of Jesus Cardiology and Valvular Institute, Sheboygan, WI 53081, USA.
Frank J SecretoDivision of General Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
K VenuprasadBaylor Institute for Immunology Research, Baylor Research Institute, Dallas, TX 75204, USA.
John R HawseDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Mayo Clinic · USWinnMed · USBaylor University · USMayo Clinic in Florida · USMost Sacred Heart of Jesus Cardiology and Valvular Institute · US

Funding

Role of a TGF-? Regulated Gene in Human and Mouse Osteoblasts and SkeletonR01DE014036 · NIDCR · MAYO CLINIC ROCHESTER · PI HAWSE, JOHN R., SUBRAMANIAM, MALAYANNAN · 2001 to 2016
$4.7M
NIDCR NIH HHS R01 DE014036
6 · The paper itself

Abstract

We have previously demonstrated that TGFβ Inducible Early Gene-1 (TIEG1), also known as KLF10, plays important roles in mediating skeletal development and homeostasis in mice. TIEG1 has also been identified in clinical studies as one of a handful of genes whose altered expression levels or allelic variations are associated with decreased bone mass and osteoporosis in humans. Here, we provide evidence for the first time that TIEG1 is involved in regulating the canonical Wnt signaling pathway in bone through multiple mechanisms of action. Decreased Wnt signaling in the absence of TIEG1 expression is shown to be in part due to impaired β-catenin nuclear localization resulting from alterations in the activity of AKT and GSK-3β. We also provide evidence that TIEG1 interacts with, and serves as a transcriptional co-activator for, Lef1 and β-catenin. Changes in Wnt signaling in the setting of altered TIEG1 expression and/or activity may in part explain the observed osteopenic phenotype of TIEG1 KO mice as well as the known links between TIEG1 expression levels/allelic variations and patients with osteoporosis.

Indexed as

Wnt Signaling PathwayAnimalsbeta CateninBone and BonesCell NucleusDNA-Binding ProteinsEarly Growth Response Transcription FactorsFemaleGene Expression RegulationKruppel-Like Transcription FactorsLigandsLithium ChlorideLymphoid Enhancer-Binding Factor 1Mice, Inbred C57BLMice, KnockoutModels, Biologicalbeta CateninDNA-Binding ProteinsEarly Growth Response Transcription FactorsKLF10 protein, mouseKruppel-Like Transcription FactorsLef1 protein, mouseLigandsLithium ChlorideLymphoid Enhancer-Binding Factor 1Transcription Factors

Identifiers

PMID28201653
PMCPMC5435970
OpenAlexW2589083800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.